Vasif Hasirci Justin J. Cooper-White Qiqing Zhang Jun Lin
Youming Zhang Name Name Name
Guoping Chen Halime Kenar Gamze Torun Köse Feza Korkusuz MD
Nesrin Hasirci Min Wang Ika Dewi Ana Wei Chen
Feng-Huei Lin Kezban Ulubayram Jinwu Wang Xudong Li
Jun Li Petek Korkusuz Kelong Fan Xiaofeng Chen
Weiming Tian Qianjun He Mingyuan Gao Tao Yi
Yongsheng Li Kui Luo Gang Liu Lei Wang
Haijun Yu Honglian Dai Name Name
Pınar Yılgör Huri Guochao Nie Yingchun Hou Bo Lei
Xingyu Chen Shili Gai Hongli Mao Yunlu Dai
Jiwei Cui Chunxia Li Ping'an Ma Xiuhua Zhao
Short biographies of speakers
Affiliation: Acibadem University & BIOMATEN (Middle East Technical University), Turkey
Vasif Hasirci has expertise in biomedical, biotechnological and nanotechnological applications of natural and synthetic polymers. He is the Founding Director of the Center of Excellence in Biomaterials and Tissue Engineering at METU, Ankara, Turkey. He retired from METU Dept. of Biological Sciences and is now a professor at Acibadem University (ACU) Dept. of Biomedical Engineering. He is the Director of ACU Biomaterials Center that he established and the Chair of the ACU Biomaterials Graduate Program. He is an Associate Editor of Frontiers in Bioengineering and Biotechnology and also of Exploration of BioMat-X and serves on the Editorial Boards of several journals including Biomaterials; Bioactive Materials, J. Biomaterials Science: Polymer Edn., and Nanomedicine. He is a Fellow of the Science Academy (Turkey), the International College of Fellows of Biomaterials Science and Engineering (IUSBSE), and Royal Society of Chemistry (FRSC)(UK). He is also a Honorary Member of the European Society for Biomaterials. He is the founding President of the Biomaterials and Tissue Engineering Society (Turkey). He is one of the initiators of BIOMED Biomedical Science and Technology Symposia in 1994. Dr. Hasirci is the recipient of Scientific and Technical Research Council (TUBITAK) Encouragement Award (1982), METU M. Parlar Science Award (2001), Sedat Simavi Medical Sciences Award (2017), HASVAK Study of the Year Award (2017).
Affiliation: University of Queensland, Australia
Professor Cooper-White was awarded his Bachelor of Engineering (Chemical) in 1991, University of Queensland, and thereafter worked for Shell (Australia) Pty. Ltd. for 5 years as a practicing chemical engineer and processing manager. He was awarded his Ph.D. in Chemical Engineering (Rheology and thermodynamics of biomedical polymers and their blends), UQ, in March 2000. He subsequently held a postdoctoral position at the University of Melbourne (UMelb) under the mentorship of Prof. David V. Boger and joined the Department of Chemical and Biomolecular Engineering at UMelb as a tenured Senior Lecturer in early 2003. In 2004, he was recruited to the University of Queensland (UQ) to head a new initiative in Tissue Engineering in the Department of Chemical Engineering and in 2007 was promoted to Professor of Bioengineering.
Professor Cooper-White has over 250 scientific publications, including >250 journal articles, 11 invited reviews and 7 book chapters, along with >150 conference abstracts. His work has been published in high impact journals (including Nature, Chemical Reviews, Advanced Functional Materials, Advanced Science, ACS Nano, Science Advances, Nature Communications, Nature Protocols, Nature Microbiology, Cell Stem Cell, Biomaterials, Biomacromolecules, Lab on a Chip, Stem Cells, Stem Cells Trans Med., APL Bioengineering), and has been cited >18,000 times (H index 69). His publications have had broad impact with 16 having >200 cites, 47 papers having > 100 cites and over 100 papers having greater than 50 citations (Google Scholar 06/02/24). ~20% and 63% of his papers are in the top 10% and top 25%, respectively, of most cited papers worldwide, ~60% are published in to the top 10% of journals, and ~40% are co-authored with international researchers (SciVal 02/2024). Many of these papers in the top 1% of papers in terms of citations in the fields of “Engineering” or “Materials Science” or “Biology and Biochemistry” for the period of 2013-2023 (Incites ESI (2013-2023)). In his topical areas of core expertise, his FWCI is 4.22 (mechanotransduction, extracellular matrix) and 1.88 (Tissue Engineering). His overall FWCI is 1.56.
Professor Cooper-White has given a total of 22 plenary, 54 keynotes, 49 Invited talks in his career, with most recent being TERMIS World Congress 2021 (Frontier); World Congress on Biomechanics 2022 (Plenary); TERMIS-Asia Pacific 2023 (Plenary). He reviews for the above listed journals along with others in his fields and has served on the National Health and Medical Research Council (NHMRC) review panels for Centres of Research Excellence (2011) and Project Grants (2012-2014), the Health Research Council of New Zealand Assessment Committee (Biomedical) (2015-2016), and the Singapore Ministry of Education Expert Panel for Life Sciences and Biomedical Engineering (2022, 2023).
Professor Cooper-White has produced 6 Worldwide patents that have reached National Phase Entry in USA, Europe and Australia in the areas of formulation design for agriproducts, microbioreactor arrays (MBAs) and tissue engineering scaffolds. Technologies developed in his laboratory has been commercialised by an Australian SME and a USA-based start-up company.
Professor Cooper-White’s research focuses on understanding the role of microenvironmental cues on stem cell commitment and tissue genesis, and the critical roles that stem cells and their niches play in systemic losses of tissue and organ function as we age. His team applies this understanding to develop biomicrodevices, engineered surfaces and advanced scaffolds for cell therapy manufacturing and engineering tissue replacement or repair, and more recently, nanoparticles for targeted rejuvenation of our aged tissues.
Affiliation: National Institute for Materials Science, Japan
Prof. Guoping Chen is Group Leader of National Institute for Materials Science (NIMS) and Professor of University of Tsukuba, Japan. He received his Ph.D. from Kyoto University in 1997 majoring in Biomaterials and did postdoctoral research until 2000. He became Researcher in 2000 and Senior Researcher in 2003 at Tissue Engineering Research Center, National Institute for Advanced Industrial Science and Technology, Japan. He moved to Biomaterials Center, NIMS as Senior Researcher in 2004 and was promoted to Group Leader in January, 2007. He served as Principal Investigator and Unit Director of Tissue Regeneration Materials Unit from April, 2011 to March, 2017. He concurrently joined the Joint Doctoral Program in Materials Science and Engineering, University of Tsukuba as Professor in 2013. His research interests include tissue engineering and regenerative medicine, polymeric porous scaffolds, photothermal scaffold, nanobiomaterials, biomimetic biomaterials, nano/micro-patterning and surface modification. He has authored more than 300 publications and holds 18 issued patents. He has given more than 150 plenary and invited lectures at conferences. He is Scientific Editor of Materials Horizons. He is Chair Elect of TERMIS-AP. He has received some awards including Young Scientist Award from Japanese Biomaterials Society in 2001, Original Research Award from Japanese Society of Artificial Organs in 2002, Tsukuba Award of Chemical and Bio-Technology from Tsukuba Foundation for Chemical and Bio-Technology in 2005, Biomaterials Advances Innovation Award 2023, Outstanding Scientist Award and Distinguished Member Award of TERMIS-AP in 2023. He is Fellow of the Royal Society of Chemistry, Fellow of American Institute for Medical and Biological Engineering and Fellow of International Union of Societies for Biomaterials Science and Engineering.
Affiliation: Acibadem University, Turkey
Dr. Halime Kenar, received her BSc degree from Department of Biology, Middle East Technical University (Turkey) in 2001 and her MSc and Ph.D. degrees from Biotechnology Department of the same university in 2003 and 2008, respectively. As part of her Integrated Natioanal/International Ph.D. Programme, she worked on stem cell biology and stem cell culture in microfluidic systems at TUFTS University Tissue Engineering Resource Center, and Massachussetts General Hospital BIOMEMS Lab, Boston, USA, respectively, in 2006. She was affiliated with Kocaeli University between 2009 and 2019, as a faculty member, where she worked as a principal investigator at the Diabetes and Obesity Research Unit and established collaborations through short visits to University of Copenhagen, Department of Biomedical Sciences (2012) and Stanford University, Bio-Acoustic MEMS in Medicine Labs (2017). Since 2019, she has been affiliated with Acibadem University Biomedical Engineering Department and Acibadem University Biomaterials Center. Her current research is focused on decellularization of human tissues, 3D printing of scaffolds and cell-laden tissue constructs, vascularization in tissue engineered constructs, diabetic wound healing, bone, muscle (skeletal and cardiac) and skin tissue engineering.
Affiliation: Yeditepe University, Turkey
Gamze Torun Köse was born in Ankara in 1972 and received her BSc degree in Biology in 1994 and her MSc degree in Biotechnology from Middle East Technical University (METU), Ankara, in 1996. She was the predoctoral fellow at the University of Texas at MD Anderson Cancer Center, Department of Immunobiology and Drug Carriers, Houston, Texas, USA, in 1998-1999 and completed her Ph.D. in Biotechnology from METU in 2002. She established Tissue Engineering and Biomaterial Laboratories at Yeditepe University, Department of Genetics and Bioengineering, in 2003 and became Associate Professor in 2006 and Professor in 2012. Since 2010, she has been Vice President of the Department of Genetics and Bioengineering at Yeditepe University. She is also a founding member of the Biomaterial and Tissue Engineering Association, established in 2008.
In 2002, she was awarded the Young Scientist Scholarship by the Biomaterial European Community (ESB 2002). She received the best thesis awards given by Prof. M. Parlar Foundation at METU with her MSc thesis on Liposomal Drug Release Systems in 1997 and her PhD thesis on Bone Tissue Engineering in 2002. In 2011, she won awards given by LOreal Turkey, Young Women in Science Scholarship, and FABED Eser Tümen Research Scholarship.
Dr. Gamze Torun Köse has 2 European patent, 4 international patent applications, more than 80 peer-reviewed research papers, and 11 book chapters (h index:31 Google Scholar). She was the advisor of 19 MSc and 14 Ph.D. students, and currently, she is the advisor of 2 MSc and 4 Ph.D. students.
Her research area is concentrated on Tissue engineering (Bone, Cartilage, Nerve, Skin); Biomaterials and Surface Modification; Stem Cells (Bone marrow, Adipocyte, Amniotic, Dental Follicle, Dental Pulp, Dental Germ); Drug or Growth Factor Release Systems; Gene Therapy; and Organoid (Parathyroid and Thyroid).
Affiliation: Hacettepe University, Turkey
Feza Korkusuz MD attended medical specification in Orthopedic Surgery and Traumatology at Gazi University Medical Faculty, Department of Orthopedic Surgery and Traumatology between 1987 and 1992 after graduating from Ankara University Medical Faculty in 1986. Between 1989 and 1990 he studied in Osaka University Faculty of Medicine, Department of Orthopaedic Surgery from where he graduated with a postgraduate diploma. His clinical and research studies focused on Spine Surgery, Sports Medicine and Basic Research. Dr. Korkusuz worked at Middle East Technical University (METU) as an orthopedic surgeon and Medical Director at the Medical Center, and at the Department of Physical Education and Sports as the Head of the Department until 2013. In 1994 and in 2001 he became Associate Professor and Professor. In 1999 and 2000, he received the METU Prof. Dr. N. Parlar Foundation young investigator and the Scientific and Technological Research Council of Turkey (TÜBİTAK) Promotion Award in Medical Sciences.
Between 1991 and 2016, he was a member to the Orthopaedic Research Society. In 2008 he became an active member of the Association of Bone and Joint Surgeons (ABJS), and since 2006 he has been the corresponding and deputy editor of Clinical Orthopaedics and Related Research (CORR). In 2017, he became an active member to the Turkish Academy of Science (TUBA). He was the Advisor to the President of TÜBİTAK between 2018 and 2021. He currently is the Chairman of the Department of Hacettepe University Medical Faculty, Department of Sports Medicine.
Affiliation: BIOMATEN (Middle East Technical University) &Near East University, Turkey
Professor Nesrin Hasirci is a member of Middle East Technical University (METU) and Near East University (NEU). At METU, she was the establisher and the first Head of the Graduate Department of Biomedical Engineering, and have been the Head of the Graduate Department of Biotechnology. She also administered as Vice Chairman of the Chemistry Department for three terms. In the years of 1994-1995, she had been at Massachusetts Institute of Technology (Cambridge, USA), as Fulbright Visiting Professor granted by Fulbright Commission. Her research area is concentrated on Biomaterials and Tissue Engineering applications of polymers and polymeric composites as well as nano and micro technology. Her works covers the synthesis, preparation and modification of polymeric materials such as, preparation of controlled and targeted micro nano drug delivery systems, novel bone cement compositions, enzyme immobilizations matrices, dental and bone supporting materials, 3D printed scaffolds, etc, and examination of surface-cell interactions of the prepared biomaterials. She has more than 250 scientific publications, 7 patents (3 approved, 4 pending), 22 chapters in scientific books, 3 edited books (2 related to Interdisciplinary Graduate Departments, 1 Scientific about Hydrogels and Biomaterials) and 2 books (as one of the two authors of the ‘Fundamentals of Biomaterials’ (Springer, 2018), and one Turkish lecture book on the same subject. She presented more than 500 talks on international and national congresses, conferences and symposia on which to some of them she was invited and been the plenary lecturer. She organized or been in the organization committees of conferences and workshops on ‘Biomaterials and Tissue Engineering’ subjects. She supervised and co-supervised more than 50 M.Sc. and 20 Ph.D. theses all related to the diagnosis and treatment of soft and hard tissues and organs.
Prof. Hasirci is honorary member of European Society of Biomaterials. She is also ‘Fellow of the Science Academy’ (Turkey). She is the owner of ‘Science Award’ given by M. Parlar Foundation and ‘Technology Award’ given by Elginkan Foundation. She is also member of Tissue Engineering and Regenerative Medicine Society, Controlled Release Society, Turkish Biomaterials and Tissue Engineering Society, Turkish Polymer Science and Technology Society, Turkish Chemical Society, Turkish Fulbright Alumni Association, etc.
Affiliation: The University of Hong Kong, China
Min Wang earned BSc (1985) and PhD (1991) degrees at Shanghai Jiao Tong University, China, and University of London, U.K., respectively. He has worked in universities in the UK, Singapore and Hong Kong. Dr. Wang joined The University of Hong Kong (HKU) in 2003 and has been a full professor at HKU since 2008 . He has also been a Guest or Adjunct Professor of several universities in mainland China. He served as Programme Director of HKU’s interfaculty Medical Engineering Programme in 2013-2018 and is currently a member of HKU’s Senate. Dr.Wang started biomaterials research in 1991 and began his work in tissue engineering in 1999. Owing to his contributions and achievements, he has been elected a fellow of several professional societies/academy in the UK, Hong Kong, USA, China and internationally (FIMMM, 2001; FIMechE, 2007; FHKIE, 2010; FBSE, 2011; FAIMBE, 2012; WAC Academician, 2013; FRSC, 2020; FCSBM, 2023).His research interests include biomedical materials, tissue engineering, controlled release, and bionanotechnology. He and his co-workers investigate fabrication technologies for tissue engineering scaffolds, including electrospinning and 3D printing, and the scaffolds developed are used to regenerate different body tissues/organs. Dr.Wang is the Series Editor of Springer Series in Biomaterials Science and Engineering since 2012 and Editor or Associate Editor of several international scholarly journals (e.g., Progress in Materials Science). He also serves/served in the Editorial Board of over 20 international journals. He is/was an elected Council Member of China’s Chinese Society for Biomaterials, World Association for Chinese Biomedical Engineers, International Federation for Medical and Biological Engineering, etc. Currently, he is Treasurer and a member of the Steering Committee of IUS-BSE’s International College of Fellows.
Affiliation: Universitas Gadjah Mada, Indonesia
Professor Dr. Ika Dewi Ana is currently a professor of the Department of Dental Biomedical Sciences, Faculty of Dentistry, Universitas Gadjah Mada and Head of Collaborative Research Center for Biomedical Scaffolds, National Research and Innovation Agency of the Republic of Indonesia (BRIN) in UGM, Yogyakarta 55281, Indonesia. Her area of interest is calcium phosphate chemistry, tissue engineering, drug and vaccine delivery system, and regenerative therapy. In her recent experiments she has been working with lung-on-a-chip for MicroLung project funded by SEA-Europe. She is also involved in BioTUNE consortium funded by MSCA to fine-tuning cellular behavior and antibacterial and immunomodulatory properties of medical implants. There are 3 research works of her (CHA Bone Graft, CHA-based Hemostatic Sponge for Oral Maxillofacial Surgery, and CHA-based Hemostatic Sponge for General and Plastic Surgery) have been already registered and translated into the market in Indonesia. Two other research works are in the pipeline for valorization: CHA-based Biomedical Membranes and CHA-based Vaccine Adjuvant.
She received national and international awards from tissue engineering and biomaterials societies related to her research. She also received Outstanding Intellectual Property Award from the Government of the Republic of Indonesia in 2014. She recently received Habibie Prize 2022 (the highest prize for Science and Technology of the Republic of Indonesia) in Medicine and Biotechnology awarded by the Government of the Republic of Indonesia. She is also receiver of WIPO (World Intellectual Property Organization) National Award for Inventor in 2023.
She has served as an Industrial Committee Member of TERMIS-AP (Tissue Engineering and Regenerative Medicine Society – Asia Pacific) since 2015 and TERMIS-AP Council since 2019. She joints a course in innovation management funded by Rolls Royce, Newton Fund, and Ministry of Research and Technology in 2017 in the Ashridge Business School, UK. She owns 18 patents and wrote 8 book chapters by Springer and Nature, Elsevier, CRC Press (Taylor and Francis), and Academic Press. Her ORCID ID is 0000-0001-9957-4247.
Affiliation: Xi’an Jiaotong-Liverpool University, China
Dr. Wei Chen is the dean for the School of CHIPS at the Xi’an Jiaotong-Liverpool University. He held the esteemed position of University Distinguished Professor within the Physics department at the University of Texas Arlington (UTA), Texas, USA. With a prolific academic career, he has authored over 350 publications in renowned scholarly journals, overseeing the compilation of three sets of books, one monograph spanning three volumes, and contributing to the creation of 15 monographs. His works have garnered significant attention, amassing more than 18,677 citations, resulting in an impressive H-index of 67. Notably, Dr. Chen has authored a paper with 773 citations and four others with over 600 citations each. His inventive contributions extend to over 22 granted US patents.
Dr. Chen's groundbreaking scientific endeavors have gained widespread recognition, notably drawing attention from CBS in the USA. In acknowledgment of his outstanding contributions, he received the University Distinguished Record of Research and Creative Activity Award in 2020. His eminence within the field was further solidified by his election as a Fellow of the International Association of Advanced Materials and a Fellow of the Royal Society of Chemistry (UK) in 2021. In 2022, he received the IMMA Scientist Award for his exceptional contributions to Nanotechnology. His remarkable achievements were acknowledged by his election as a Fellow for the US National Academy of Inventors in 2022 and as a member of the University Academy of Distinguished Scholars in 2023, the highest honor and recognition at UTA.
Dr. Chen also served as the Director of the Center for Security Advances Via Applied Nanotechnology (SAVANT) from 2012 to 2018, showcasing his leadership and vision in the field. He used to be the deputy director for the laboratory of Semiconductor Materials at the Institute of Semiconductors, CAS and he received the outstanding young scientist award from CAS.
Affiliation: Harbin Engineering University, China, Guest Professor
1. Dept. Mater. Sci., National Cheng-Kung University, Taiwan, Ph.D., 1985/09~1989/11, Institute of Materials Sciences, Biomaterials;
2. Dept. Mater. Sci., National Cheng-Kung University, Taiwan, Master, 1983/09~1985/06, Institute of Materials, Biomaterials;
3. Dept. Earth Sci., National Cheng-Kung University, Taiwan, Bachelor, 1976/10~1980/06, Dept Earth Science
Experiences
1. 2023/05- Guest Professor, Harbin Engineering University
2. 2022/09- Researcher, IBEN, National Health Research Institute (NHRI)
3. 2012/08-, Tenure Distinguish Prof., Inst. of Biomed.Eng., NTU
4. 2014/08-2022/09, Director, Institute of Biomed Eng, NHRI, Taiwan
5. 2008/08-2011/07, Director, Biomed.Eng. Div., NHRI
6. 2006/12-2009/12, Convivision, Dept Eng. & Appl Sci., NSC, Taiwan
7. 2005/08-2008/07, Director, Inst. Biomed. Eng., NTU
8. 2002/08-2005/07, Director, Dept. Biomener, BME Ded. Eng., NTU-Hospital
Editorial Board Member (selected)
1. International Journal of Molecular Sciences, (SCI, IF 6.208), 2017-1103-,
2. Frontiers in Bioengineering and Biotechnology, (SCI, IF 6.064), 2018-0501-,
3. The Journal of APL Bio-engineering, (SCI, IF 6.578) 2020-01-
Editor-in-chief
Journal of Biomedical Engineering, (SCI), 2007-2011
Research interest：Biomaterials, Regenerative Medicine
Over 500 SCI published since 1990; Discipline H-index 70; citations 16,228; World top 2% scientists consecutive 4 years (by Stanford University, USA); Ranking 32 in Materials Sciences.
Affiliation: Hacettepe University, Turkey
Kezban Ulubayram is a full professor in the Departments of Basic Pharmaceutical Sciences and Bioengineering at Hacettepe University, Turkey. She graduated with a degree in Chemistry from Middle East Technical University (METU) in 1988 and earned her PhD in Biotechnology from METU in 1997. Following this, she conducted postdoctoral research in tissue engineering at Prof. Langer Laboratory, Massachusetts Institute of Technology.
Since 1999, Prof. Ulubayram has pursued her career at Hacettepe University, in the Department of Basic Pharmaceutical Sciences. Her current research focuses on biomaterials and cells, with the goal of advancing transdisciplinary concepts for applications in regenerative and personalized medicine. She holds a patent for a tissue engineering product that has been commercialized as a wound dressing.
Prof. Ulubayram has authored over 100 peer-reviewed articles and numerous book chapters on biomaterials and regenerative medicine. She is a member of several professional societies including the European Biomaterials Society, Tissue Engineering and Regenerative Medicine Society, Turkey’s Biomaterials and Tissue Engineering Society, and the Chemistry Society.
Affiliation: Ankara University, Turkey
Dr. Yilgor Huri is currently a Professor of Biomedical Engineering at Ankara University. She held a postdoctoral appointment at Johns Hopkins University School of Medicine prior to joining Ankara Uni. She received her PhD degree from METU and was also awarded an Integrated European PhD within the scope of FP6 Network of Excellence Expertissues. Her research is in the area of tissue engineering and regenerative medicine including stem cell research and engineering of bio-inspired systems mainly using 3D printing technology. She is particularly interested in the development of functional biomaterial platforms to enhance tissue regeneration characteristics that would lead to translatable therapies, with 2 translated products and several issued and pending patents. Dr. Huri's research achievements include several awards such as, Ankara University Incentive Award (2020), METU Parlar Award (2018), Health Institutes of Turkey Aziz Sancar Incentive Award (2017), Turkish Academy of Sciences Outstanding Young Scientist Award (2016) and The American Society for Bone and Mineral Research Young Investigator Award (2013).
Affiliation: Shanghai Jiao Tong University, China
Jinwu Wang , Doctor of Medicine, Chief Physician of Orthopedics at the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, FELLOW of Orthopedics at Cleveland Medical Center in the United States, Professor at Shanghai Jiao Tong University School of Medicine, part-time researcher at the School of Biomedical Engineering at Shanghai Jiao Tong University, doctoral supervisor, and postdoctoral supervisor. Chief Scientist of the Two National Key R&D Plans of the Ministry of Science and Technology during the 13th and 14th Five Year Plans, International Foreign Academician of the Russian Academy of Natural Sciences, Chief Scientist of the Institute of Translational Medicine at Shanghai Jiao Tong University, and the 5th Outstanding Achievements People's Famous Doctor. Director of the National Major Science and Technology Infrastructure for Translational Medicine (Shanghai) Innovation Medical Device Registration Research and Clinical Transformation Service Center, Director of the Digital Medicine and Biological 3D Printing Laboratory, Deputy Director of the Engineering Research Center for Digital Medicine Clinical Transformation of the Ministry of Education, Deputy Director of the Key Laboratory of Intelligent Control and Rehabilitation Technology of the Ministry of Civil Affairs, Deputy Director of the Engineering Research Center for Traditional Chinese Medicine Intelligent Rehabilitation of the Ministry of Education, Acting Chairman of the Shanghai Digital Medicine Specialized Branch of the Chinese Medical Association, Deputy Chairman of the Digital Orthopedic Trauma and Joint Committee of the Chinese Medical Association, Evaluation Expert of the National Food and Drug Administration (NMPA), Excellent Technical Leader of Shanghai, Key Discipline Leader of the Bone and Joint Rehabilitation Medicine Department of the Shanghai Municipal Health Commission, Leading Talent in Clinical Rehabilitation of Shanghai, and Shanghai Rehabilitation Medicine Engineering Research Association Chairman, Vice Chairman and Secretary General of the Shanghai Rehabilitation Aids and Elderly Welfare Industry Technology Innovation Strategic Alliance, Vice Chairman of the Digital Orthopedics Special Committee of the Medical Engineering Branch of the Chinese Medical Association, Vice Chairman of the Sports Medicine Professional Committee of the Chinese Research Hospital Association, Vice Chairman of the Advanced Manufacturing Branch of the Biomaterials Society of China, and Vice Chairman of the 3D Printing Technology Branch of the Chinese Medical Biotechnology Association.
We have been committed to the fields of orthopedic surgery, digital medicine, 3D printing of bone and joint biology, and orthopedic rehabilitation for a long time. Our biological 3D printing project has been featured in a special report by Nature. We have undertaken 10 national level projects, including the 13th Five Year Plan Key R&D Program of the Ministry of Science and Technology (Biological 3D Printing), the 14th Five Year Plan Key R&D Program of the Ministry of Science and Technology (Digital Medicine and Micro Nano Biomaterials), the 863 and 973 sub projects of the Ministry of Science and Technology, and the China Engineering Science and Technology Development Strategy Consulting Project. Obtained the first 3D printed medical device registration certificate in China, as well as the first medical device registration certificate applied for by scientific research enterprises under the registrant system. Led the development of 14 medical device standards, including the first biological 3D printing standard and the first 3D printed rehabilitation accessory standard in China. The completed 3D printed lunar bone is one of the smallest joints in human 3D printing. This achievement has been applied for and obtained an invention patent, and has been clinically applied for transformation. Associate Editor in Chief of Digital Medicine and Tissue Engineering and Reconstructive Surgery; Participated in the compilation of 19 monographs, with 12 monographs as chief or deputy chief editors, 1 chief translator and 1 deputy chief translator. Published over 100 high-quality papers as first author or corresponding author, including sub journals of Nature and Science. Established a graduate program on the cross transformation of digital medicine and 3D printing in cutting-edge medical engineering at Shanghai Jiao Tong University, and was awarded the title of Scientific Chinese Person of the Year (2016).
Won the first prize of Shanghai Technology Invention Award in 2022 as the first person to complete the project titled Key Technologies and Equipment Development for Digital Diagnosis and Treatment of Quadrilateral Osteoarthritis. Has won the first prize of Science and Technology from the Ministry of Education, the first prize of Shanghai Medical Science and Technology, the first prize of Shanghai Rehabilitation Medicine Technology, the first prize of Chinese Medical Science and Technology Progress, the Jiangsu Medical Science and Technology Award, and the first prize of Jilin Province Science and Technology.
Affiliation: Sichuan University, China
Mr Xudong Li, obtained his PhD degree at Queen Mary, University of London, is now a professor of biomaterials in the National Engineering Research Center for Biomaterials, and the School of Biomedical Enginering, Sichuan University, PR China. He was the vice chairman of the first Bioceramic Branch of the Chinese Society of Biomaterials. His research experience covers calcium phosphate (CaP) bioceramics, hydroxyapatite (HAP) coatings/films, inorganic/organic composites, biomimetic mineralization/inorganic morphogenesis (CaP, calcium carbonate and calcium oxalate), collagen and keratin protein biomaterials, polysaccharides and plant polyphenols. His studies have been selected as research highlights by ACS, RSC and Nature China. His current research interests mainly focus on developing novel injectable biomaterials for tissue repair and regeneration as well as synthesizing therapeutic nanoparticles based on naturally reproducible products for regenerative medicine.
Affiliation: National University of Singapore, Singapore
Prof. Li Jun received his PhD (1995) and MSc (1992) in macromolecular science from Osaka University, Japan. He is currently a Professor in Department of Biomedical Engineering at National University of Singapore (NUS). He is also a Principal Investigator at NUS Environmental Research Institute, NUS (Chongqing) Research Institute, and NUS (Suzhou) Research Institute. Before joining NUS, he worked as a Senior Scientist at the A*STAR Institute of Materials Research and Engineering, and as a Special Postdoctoral Researcher at the RIKEN Institute in Japan. Prof. Li’s expertise lies across the synthetic and bio-based polymers, and their supramolecular self-assemblies forming nanostructures for various applications such as drug and gene delivery, tissue engineering, personal care, and environmental sustainability. So far, he has published more than 210 articles in international journals including Nature, Nature Biomedical Engineering, Nature Water, Science Advances, Advanced Materials, Advanced Functional Materials, JACS, Angew Chem, Biomaterials, etc., which have received more than 16,800 citations with an h-index of 71. He filed 12 patents, authored a few book chapters, and edited one research book. He served chairs/co-chairs for 6 international symposia/conferences on the topics of bio-based polymers, hydrogels, and biomaterials, and supramolecular chemistry.
Affiliation: Yulin Normal University, China
Professor, Nanning City C category of excellence. Research direction is nanomaterials and biomedical applications. He is a visiting scholar and postdoctoral fellow at the University of Michigan, USA. He is a member of the Chinese Chemical Society, Chinese Optical Society, Chinese Optical Engineering Society, Chinese Chemical Society, the first director of the Shenzhen Medical Research Promotion Association, a member of the Guangxi Council of the European and American Association, and a member of Nordic Zero Carbon Committee of European and American Association. Director of China-Ukraine Joint Research Centre for Nano Carbon Black. The first batch of university student innovation and entrepreneurship instructors in Guangxi. He is an expert in the evaluation of science and technology projects in Guangxi, Chongqing, Jiangxi, and Hebei Provinces (cities and Provinces) and an expert in the online evaluation of the National Natural Science Foundation. Master's supervisor at Shaanxi Normal University and visiting professor of Shenzhen Research Institute of Chinese Academy of Sciences. He completed two projects for the National Natural Science Foundation of the PRC as PI and is now presiding over 1 project of the Ministry of Science and Technology for high-end talents and 1 major special project of Guangxi Province for innovation-driven development. He has chaired and completed 5 projects of the Guangxi Province Science and Technology Program, including 2 projects of the Key Research Program. He is also in charge of the project Yongjiang Plan for the leading talents of innovation and entrepreneurship in Nanning City. He has obtained 11 registrations of scientific and technological achievements in Guangxi, applied for 50 invention and utility model patents, and obtained 21 authorizations. In the past three years, He has published more than ten SCI Q1 and Q2 manuscripts. He has guided students to win 80s awards from the Guangxi Province and China in innovation and entrepreneurship competitions. He has won four national silver and bronze medals, and more than ten special prizes (gold medals) in Guangxi, such as the National Student Challenge Cup and the National Student Connect+ Competition.
Affiliation: Shaanxi Normal University, China
Physician of Xi’an Xi-Jing Hospital in 1997-1998. Postdoctoral Scholar, Postdoctoral Research Associate and Senior Scientist at American NIH, Wayne State University and VA Medical Center in 1998-2006. From 2006 to date, the professor of molecular cellular biology at Shaanxi Normal University.
More than 100 papers were published by the journals in American or China. 12 Chinese invention patents were empowered. Co edition for 3 scientific and text books.
The scientific theories of “Spatiotemporal Cell Biology” was first concluded in the world, and the scientific concepts including “Spatiotemporal Cell Biology”, “Triple W”, “Physiological Triple W”, “Pathological Triple W”, “Cell community”, “Signal basin”, “GTP core” and “Three Immunity Statuses against Viral Infections in Human” were first proposed and published in the world.
Part-time Academic Positions:
1. The professor of Northwest University
2. Reviewer of the National Science and Technology Award and Education Ministry Science and Technology Award in China
3. Vice Chairman of the Society of Human Medical Genomics in Shaanxi Province
The Current Research Interests:
1. The molecular cellular theranostic researches of cancers
2. The bio-panning and characterization of cancer targeting molecular fragments
3. The development of novel drug formulations for cancer targeting chemotherapy
4. The gene function and signal transduction relevant with cancers
5. The bioinformatics of cancers
Affiliation: Xi’an Jiaotong University, China
Professor Bo Lei got his Ph.D degree in Biomedical Materials from South China University of Technology, China in 2010. From 2011 to 2013, he worked as a research professor in the department of dental materials of Korea University, South Korea. Then he became a full Professor at the Frontier Institute of Science and Technology in Xi’an Jiaotong University in 2013. Professor Lei has published more than 100 peer-reviewed SCI papers in the field of Biomaterials Science including Materials Today, Advanced Functional Materials, Angew Chem Int Edit, ACS Nano, Nano Letters, Biomaterials and so on. His research interests are focused on the design and fabrication of bioactive nanoscale biomaterials for disease therapy and tissue regeneration.
Affiliation: Southwest Jiaotong University
Dr. Xingyu Chen is an associate professor at Southwest Jiaotong University. Her research focuses on smart gels/microneedles for the repair of chronic wounds or ulcers. She has chaired several fundings, including three National Natural Science Foundations. She has also published 31 SCI papers in Adv. Mater., Biomaterials, J. Control.Release, and other journals as the first or corresponding author. All the papers have been cited for more than 2200 times, H-index 28. She has applied for 14 invention patents (5 authorized). She cooperates with companies to develop wound repair dressings (Class II) and Wound repair microneedles (Class III). Serves as the director of Sichuan Women Science and Technology Workers Association.
Affiliation: Hacettepe University, Turkey
Born in Ankara, Petek Korkusuz graduated from Tevfik Fikret French High School in 1985 and received her M.D. degree from Gazi University Faculty of Medicine in 1991. She completed her residency in Medical Histology and Embryology at Hacettepe University Faculty of Medicine in 1997 with her thesis entitled ‘Assessment of Cell Adhesion Molecules in Osteoarthritic Synovia by Using Immunohistochemistry and Electron Microscopy’. She received her Ph.D. in 2000 from Gazi University Faculty of Medicine Department of Medical Pharmacology with her thesis on ‘The Roles of Endothelium Derived Factors on Digoxin Induced Arrythmia in Isolated Perfused Guineapig Heart Model’. Her professional appointments include Assistant Professor position in 1998, Associate Professor (award of tenure) in 2003 and full Professor in 2010 (present position) in Hacettepe University Faculty of Medicine Department of Histology and Embryology. Her secondary appointments are in Middle East Technical University METUMEMS Center in Hacettepe University Department of Nanomedicine and Nanotechnology, Department of Bioengineering, Department of Stem Cell Sciences and, Department of Oral Biology. She received the Turkish Scientific and Research Council (TUBİTAK-BAYG) National Doctoral Scholarship between 1991 and 1993. She studied cell culture techniques in 1993 in Bordeaux University INSERM Laboratory France, learned basic hybridoma technology and lymphocyte homing mechanisms in 1997 and 1998 in Osaka University Department of Bioregulation Japan, worked on phage display technology and electron microscopic screening of phages in 1999 in Erasmus University Immunology Department and Electron Microscopy Unit Netherland with a postdoctoral NATO-B1 scholarship. She was a visiting professor of Harvard and Yale Universities IPSC Centers in 2015 and 2016 respectively. She has 3036 citations for 178 Science Citation Indexed publications with an h index of 29 in WOS and, 5062 citations with an h index of 35 in Google Scholar on May 2024. She owns 9 patents, several international and national book chapters and awards. Her research is focused on cell therapeutics for regenerative medicine; niche-based strategies for nanobiomaterial implemented, stem cell assisted or cannabinoid mediated soft/hard tissue engineering, cancer and male infertility treatment. She is an active member of the International Stem Cell Research Society, European Society of Gene and Cell Therapy, European and Turkish Microscopy Societies, European and American Orthopedic Research Societies, European Society for Molecular Oncology, American Society for Reproductive Medicine, European Society of Reproductive Endocrinology, European and Turkish Pharmacology Societies and, past president and board member of Turkish Histology and Embryology Society.
Affiliation: Harbin Engineering University, China
Shili Gaireceived a B. S.degreemajored in chemical engineering and technology from Harbin Engineering University, China in 2009, andPh. D. degree (materials science) fromHarbin Engineering University, China in 2013. After graduation, she has been working as an associate professor in Harbin Engineering University (China) since 2014, then working as a professor in Harbin Engineering University (China) since 2020.She has focused on the study of multifunctional (magnetic,luminescent, prorous etc.) materials for therapyand bioimagingabout 15 years, and published more than 200 peer-review papers in scientific journals, some of which are top journals in the area of materials, including Chem. Rev., Chem. Soc. Rev., J. Am. Chem. Soc. (Cover), Adv. Mater., ACS Nano, Adv. Funct. Mater., andthese articles have totally been cited over 17000 times by others with a personal H index of 72 (Google Scholar). Besides, she won two Grade -1 Awards for Science andTechnologyof Heilongjiang Province in 2019 and 2017.
Affiliation: Nanjing Tech University, China
Hongli Mao, PhD/Professor, College of Materials Science and Engineering, Nanjing Tech University. In 2014, he graduated from the University of Tsukuba and the National Institute of Materials Science (NIMS) of Japan with a Doctorate in Engineering. Later, he engaged in postdoctoral research at RIKEN and was supported by the JSPS postdoctoral fellowship. In 2017, he joined Nanjing Tech University. At the same time, he is also a guest researcher of Guangdong Academy of Sciences, director of the joint R & D center of Nanjing Tech University - Shinva Ande Healthcare Apparatus Co.,Ltd, academic committee member of Biomedical Polymer Branch of Chinese Society for Biomaterials, academic committee member of Biomaterials Branch of Chinese Society of Biomedical Engineering. His main research interests include biomaterials, tissue engineering, regenerative medicine, 3D bioprinting, stem cells and so on. Up to now, he has published over 60 peer reviewed papers (H-index = 19) in Advanced Materials, Advanced Functional Materials, Biomaterials and other academic journals, and owned 18 patent applications.
Affiliation:Changchun Institute of Applied Chemistry Chinese Academy of Sciences, China
Dr. Jun Lin, professor, and the group leader of luminescent and biomedical materials in Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. His research mainly focuses on luminescent materials for various applications, including photoluminescence and spectral properties of rare earth ions and peroskite QDs for applications in displays and lightening (especially for white LED), as well as multifunctional materials as theranostic agents for biomedical applications. He won Grade -1 Award for Science and Technology Progress of Jilin Province three times, and was selected in highly cited researchers in materials science and cross-field in 2014-2023.So far he has published more than 900 peer-reviewed journal articles, including Chem Rev(1), Chem Soc Rev(7), Adv Mater(25), J Am Chem Soc(7) and Angew Chem Int Ed (20) etc, with total citations over 80000 and H index of 145; He also gave more than 100 invited lectures in various kinds of conferences.
Affiliation: South China University of Technology, China
Xiaofeng Chen is Professor and Ph.D. Advisor of Department of Biomaterials, School of Materials Science and Engineering, South China University of Technology. Vice Chairman of the Chinese Society of Biomaterials and Chairman of the Bioceramics Branch, Fellow of the Chinese Society of Biomaterials, Fellow of the International Federation of Biomaterials Science and Engineering, Member of the National Surgical Implants and Orthopedic Devices Standardization Technical Committee, Member of the National Biomaterials Innovation Cooperation Platform Expert Committee.Prof. Chen has specialized in BG research for more than 20 years including bioactive glass and ceramic, sol-gel and nanomimetic synthetic bioactive glass, the interaction between materials and cells and their tissue repair mechanisms, bone, tooth and skin wound repair materials and product development. He has presided over more than 20 sub-projects of national 973, 863, support Plan projects, National Natural Science Foundation key funds, joint funds and surface projects, national 13th Five-Year key projects (projects), and Guangdong Province key science and technology plan projects.
Affiliation: Harbin Institute of Technology, China
Tian Weiming, a professor of Harbin Institute of Technology, serves as the chief designer of the Space Life Science direction of the National Development and Reform Commission's major scientific engineering project (Ground Simulation of Space Environment), chief scientist of the National Key R&D Program, and editorial board member of the National Key Publishing Project Biomedical Engineering. He is engaged in research on aerospace medicine and biomaterials, and has published over 60 papers in the Nature Communications, Acs Nano, Chemical Engineering Journal and other journals.
Affiliation: Institute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, China
Qiqing Zhang is professor, doctoral supervisor, researcher of second grade and deputy director of the Academic Committee of Institute of Biomedical Engineering, Chinese Academy Medical Sciences & Peking Union Medical College, Tsinghua University School of Medicine, professor and doctoral supervisor of Macau University of Science and Technology. He has been engaged in the research of regeneration and repair of defect caused by injury, tumor, retrogression, etc. by combining diagnosis, precaution, intelligent medical bio-material, tissue engineering, additive manufacturing, nanotechnology, stem cell technology and controlled release drug preparation for about 40 years. As project leader, Prof. Zhang has undertaken 203 research projects including Major Research Projects of National Natural Science Foundation of China, National Science Funds for Distinguished Young Scholar, 863, 973, National Support Plan and National Key Research, Development Plan for the 13th Five-year Plan. He has published 720 papers which have been cited over 21857 times with H-index of 72, compiled and co-compiled 15 monographs and guidelines, and led the setting of the first national industrial standard for absorbable surgical suture. He has been granted and authorized 273 patents. He has 15 industrialized achievements, 9 class-III medical device registration certificates, 1 health product license, 1 export sales certificate of medical device products, 1 European CE IVD certification, 1 Vietnam import and export license, 1 Russian certification, 1 British ISO certification. His products have been widely used in neurosurgery, orthopedics, stomatology, oncology, ent, plastic surgery, cardiovascular surgery, tendon rupture and organ perforation. He has tutored 6 post-doctors, 51 doctors and 297 masters' students.
He was rated as: Foreign Full Member (Academician) of Russian Academy of Engineering, Fellow of Royal Society of Chemistry, Fellow of Chinese Society of Micro-nano Technology, Candidate for Academician of the Chinese Academy of Sciences, Leading Talent of Ten Thousand Plan - National High Level Talents Special Support Plan, etc. (40 in total) for his outstanding contribution to the field of biomaterials. He has won 47 awards, including the China's Government Friendship Award (organizer), China's Industry-university-research Cooperation Innovation Achievements, Second prize for technical invention of Ministry of Education of the People's Republic of China, and National Outstanding Innovation of China. He was selected into the Lifetime Scientific Influence Ranking and Annual Scientific Influence Ranking of the world's top 2% scientists in 2023, and was compiled into the Peking Union Medical College Elite.
Affiliation: Center of Hydrogen Science, Shanghai Jiao Tong University, China
Qianjun He earned his PhD in 2010 from Shanghai Institute of Ceramics, Chinese Academy of Sciences, and was then assigned as an Assistant Professor there. He received a Marie Curie Fellowship and moved to University of Leeds in 2012. After two years, he joined the Laboratory of Molecular Imaging and Nanomedicine, NIBIB, National Institutes of Health (NIH), as a postdoc. In 2015, he joined Shenzhen University as a Full Professor and the Chief of the Lab of Advanced Nanomedicines. In 2022, he moved to Shanghai Jiao Tong University (SJTU) and was appointed a Distinguished Professor and the Director of the R&D Center, Shenzhen Research Institute of SJTU. His research focuses on the engineering and development of intelligent nanomaterials and nanomedicines for precision gas therapy of major diseases. He has pioneered a unique research field of “nanomaterials-mediated gas therapy”, and has published 100+ papers with an h-index of 62 on leading journals including Science Advances, NatureCommunications, and AdvancedMaterials. He was recognized as a “Highly Cited Researcher” and as a “World’s Top 2% Scientists” with Career Scientific Impact (2020‒2024). He is sitting the Associate Editors of MedicalGasResearch and ChemicalSynthesis. Recently, he has received “National Distinguish Young Scientists Foundation”.
Affiliation: University of Macau, China
Dr. Yunlu Dai is an associate professor in the Faculty of Health Sciences, University of Macau. He received his Ph.D. degree in 2014 from the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. After his postdoctoral research at the University of Melbourne and National Institutes of Health (NIH). He initiated an independent research program at University of Macau as an assistant professor in 2018. He was promoted to associate professor in 2022. His research team mainly focuses on multifunctional hybrid nanomaterials for biomedical applications.
Affiliation: School of Life Sciences, Soochow University, Suzhou, China
Dr. Gao is a full Professor at Soochow University. He received his BSc (1989) and PhD (1995) in Polymer Chemistry and Physics at Jilin University. He was a postdoc and an AvH fellow between 1996 and 1998 at Max-Planck-Institute of Colloids and Interface, and a group leader between 1998 and 2001 at University of Munich, Germany. He was appointed as a full professor in the Institute of Chemistry, Chinese Academy of Sciences in 2001. He received an award for Distinguished Young Scholars from NSFC in 2002. In 2013, he was appointed as a Chair Professor and Director of the Centre for Molecular Imaging and Nuclear Medicine, Soochow University. He completely moved to Soochow University at the end of 2020. He is currently the Dean of School of Life Sciences. With a cumulative impact factor (IF) point of 2370+, he has published 250+ peer-reviewed articles and the total citation number is 26000+.
Affiliation: College of Chemistry and Chemical Engineering, Donghua University, Shanghai, China
Tao Yi, received her BSc (1987), M. S. (1990) and Ph. D. degrees (1998) from Peking University. She joined Kyoto University as a JSPS postdoctoral fellow in the period of 1999-2001 and worked as a research fellow in University of Tokyo and Paris University (XI) (CNRS) from 2002 to 2004. After that she joined Fudan University as an associate professor (2004) and became a full professor in 2007 in the department of chemistry. From 2021, she became a full professor and research leader of Donghua University. Her research interests focus on stimulus responsive functional materials, biosensors, imaging and therapy. She has authored more than 240 peer reviewed publications with more than 15000 citation. Her h-index is 65.
Affiliation: East China University of Science and Technology
Yongsheng Li is professor in School of Materials Science and Engineering, East China University of Science and Technology (ECUST). He received his PhD degree from Dalian University of Technology in 2001 ( with Prof. Shucai Guo and Prof. Jinqu Wang). After his postdoctoral research in Shanghai Institute of Ceramics, CAS (with Prof. Dongsheng Yan and Prof. Jianlin Shi) and Institut de Recherches sur la Catalyse et l’environnement de Lyon CNRS, France (with Prof. Jean-Alain Dalmon), he joined in ECUST and was promoted as a full professor in 2009. From 2020, he was also a professor in Shihezi University. His research mainly focuses on hybrid biomaterials, hierarchically porous materials for biomedical and catalytic applications. He has published more than 200 peer-reviewed scientific papers on Nature Commun., Chem., J. Am. Chem. Soc., Angew. Chem. Int. Ed., Adv. Mater. etc. with over 15000 citations.
Affiliation: Shandong University, China
Jiwei Cui is a Professor in the School of Chemistry and Chemical Engineering at Shandong University. He received his PhD in colloid and interface chemistry from Shandong University in 2010 and worked as a research fellow in the Department of Engineering at The University of Melbourne during 2010-2016. During this time, he was awarded an ARC Super Science Fellowship. Prof. Cui serves as an editorial board member of Ultrasonics Sonochemistry, Chinese Chemical Letters, and BMEMat. He has published over 70 peer-reviewed papers as the corresponding author in last five year. His research interests include colloid assembly, interface engineering, bio-nano interactions, and therapeutic delivery.
Affiliation: Shandong University, China
Chunxia Li received her B.S. (2002) and M.S. (2005) in chemistry from Northeast Normal University, and a Ph.D. degree (2008) from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences. After graduation, she became an Assistant Professor in Prof. Jun Lin’s group and was promoted to Associate Professor in 2012. She worked at Zhejiang Normal University during 2016-2019. Then since Apr. 2020 she has been working as a professor at Shandong University. Her current research interests include the controllable synthesis of multifunctional nanomaterials and their bio-application. She was selected in Thomson Reuters (Clarivate) Highly Cited Researchers for 5 times and Elsevier China's Highly Cited Scholars in 2015-2023. So far, she has published more than 200 peer-reviewed journal articles, such as Chem. Soc. Rev., Adv. Mater., Angew. Chem. Int. Ed. etc., and these articles have totally been cited over 27,000 times by others with a personal H index of 94 (Web of Science).
Affiliation: West China Hospital, Sichuan University, China
Dr. Luo was appointed as Assistant Professor in this center at the same university upon completion of his PhD study. From 2009 to 2011, he carried out his postdoctoral research on polymeric nanomedicines at the Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, USA. After returning to Sichuan University, Dr. Luo was promoted to Associate Professor in 2012 and Full Professor in 2013. Since 2016, he is Full Professor and Principal Investigator (PI) at the West China Hospital, Sichuan University, China.
Dr. Luo’s research in the past few years has been focused on stimuli-responsive and biodegradable polymeric gene/drug delivery vehicles and imaging probes for cancer diagnosis and therapy. The main thrust of his research is on the development of stimuli-responsive, biodegradable and functionalized synthetic macromolecules (including functional polysaccharides, synthesized linear and dendritic polymers) as cancer therapeutic and diagnostic agent candiates, and the elucidation of the relationships between their actions and structural features. The multidisciplinary thrust drives him collaboration with experts in clinical medicine, biomedicine, pharmaceutics, imaging, polymer chemistry, organic and physical chemistry and molecular biology.Since 2012, he has presided more than ten projects, including the International Science and Technology Cooperation Program of the Ministry of Science and Technology (MOST), the subprojects of the Support Program of The MOST, the National Natural Science Foundation of China (six projects), the Outstanding Youth Science Foundation of Sichuan Province, and the International Cooperation Program of Sichuan Province. He has participated in four national projects as a project leader or a core team member, including the 973 Program for Biomaterials, the National Key New Drug Research Program, and the National Key Research and Development Program. He has published more than 80 research papers in prestigious academic journals with an impact factor(IF) >10, and he has received >7000 citations with an H-index of 58. In the past 5 years, he has published more than 60 papers as a corresponding author in top-ranked journals in clinical medicine, medical technology, materials, pharmacy and other journals with an IF>10, among which 19 papers has been published in Adv. Mater. (IF=29.4), and 12 and 20 papers have been selected as “ESI Hot Papers” and “ESI Highly Cited Papers”, respectively. In addition, he has authorized 15 Chinese invention patents (one transferred), and received one first prize in Natural Science from the Ministry of Education.
He serves as Vice Chairman of the Bio-based Materials Committee of the Chinese Society of Biotechnology, an Executive Member of the Imaging Technology Branch of the China Medicinal Biotech Association, a member of the Nanobiology Academic Subgroup of the Biophysical Society of China, a member of the Imaging Materials and Technology Branch of the Chinese Society for Biomaterials, and a member of the Biomedical Polymer Materials Branch of the Chinese Society for Biomaterials.
Affiliation: Xiamen University, China
Gang Liu is a professor at Xiamen University in China. He received his MD degree from North Sichuan Medical College (China) in 2002 and PhD degree from Sichuan University (China) in 2009. Subsequently, He focused his training on nanomedicine and molecular imaging at the National Institutes of Health (NIH) (2009-2011). In 2012, Dr. Liu joined the Center for Molecular Imaging and Translational Medicine (CMITM), Xiamen University. He is now working in the field of Biomedical Engineering to develop various bio-inspired nanomaterials for cancer theranostics. His scientific work has been published as 200+ papers in prestigious journals (Adv. Mater., Nat. Nano., PNAS, etc.), 17 invited book chapter, and 20 patents. Now he is serving as editorial board members for several journals including Am J Nucl Med Mol Imaging, Curr Mol Med, and Quant Imaging Med Surg.
Affiliation: National Center for Nanoscience and Technology, China
He works on biomimetic biomedical materials, such as biomimetic ECM peptidic materials, and develops recognition-capture-therapeutics strategy. He is the Distinguished Young Scholars supported by Natural Science Fund of China. He has published 120+ scientific papers. He has applied more than 30 patents, 5 of which have been transferred to companies.
Affiliation: Institute of Biophysics, Chinese Academy of Sciences, China
Kelong Fan received his Ph.D. degree in cell biology from the Institute of Biophysics, Chinese Academy of Sciences, in 2014. After this period, he stayed there to further pursue 3 years of postdoc training and 2 years of associate professor work experience before attaining a full professor position in 2019. He is interested in exploring the novel functions and applications of nanozymes in biomedicine, with a top priority to design functional nanozymes by learning from nature, and to develop novel strategies for disease theranostics. He now serves as the Deputy Editor of Exploration, and has been recognized as a “highly cited researcher” by Clarivate since 2022.
Affiliation: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China
Prof. Haijun Yu is a professor and principal investigator in Shanghai Institute of Materia Medica, Chinese Academy of Sciences. He obtained his Ph.D. in Polymer Chemistry and Physics in 2006 at Changchun Institute of Applied Chemistry, CAS. He conducted postdoctoral research at Ludwig-Maximillians University, UTSouthwestern Medical Center and Tohoku University. His group is devoted to developing novel drug delivery systems and clinical translation for cancer immunotherapy. His group has developed a set of stimuli-activatable and prodrug-based drug delivery systems with improved drug delivery efficacy and therapeutic performance by overcoming the pathophysiological barriers of solid tumors. Prof. Yu has authored and co-authored over 170 peer-reviewed journal publications including Sci Immunol, Nat Commun, Sci Adv, Adv Mater and so on, with a total citation over 16000 and H-index of 72. He also severs as the editorial board members of several peer-reviewed journals, including Journal of Gene Medicine, Chinese Chemical Letters and so on.
Affiliation: Changchun Institute of Applied Chemistry Chinese Academy of Sciences, China
Dr. Ma is a full Professor at Changchun Institute of Applied Chemistry Chinese Academy of Sciences (CIAC). He received his BSc (2005) and PhD (2010) in Biochemistry and Molecular Biology at Northeast Normal University (NENU). After that he joined CIAC as an associate professor (2010) and became a full professor in 2020 in State Key Laboratory of Rare Earth Resource Utilization. His research interests focus on nanomaterials mediated reactive oxygen species (ROS) homeostasis regulation and tumor immunotherapy. He has authored more than 150 peer reviewed publications with more than 12000 citations.
Affiliation: Wuhan University of Technology, China
Professor Honglian Dai is currently a researcher in State Key Laboratory of Advanced Technology for Materials Synthesis and Processing at Wuhan University of Technology and also works as a Deputy Director at Biomedical Materials and Engineering Research Center of Hubei Province.Herresearch areas focus on the research and development of biomedical materials and medical devices, mainly including tissue repair and regeneration materials, injectable biomaterials, magnetic biomaterials, drug-controlled release materials and biological 3D printing, etc. She held and participated in more than 40 research fundings including the National Key Technologies R & D Program of China, National Program on Key Basic Research Project and National Natural Science Foundation of China, etc. She published about 163 papers in international journals including Sci. Adv., Adv. Fun. Mater., Biomaterials and has been granted 49 national invention patents and 3 European and American patents.She held 4 National Registration Certificate for Class III Medical Device, which benefited more than 500,000 patients.She also serves as theexecutive director of Chinese Society for Biomaterials, the deputy director committee of Nerve Repair Materials Division ofChinese Society for Biomaterials, the committee of Biological Composite Materials Division of Chinese Society for Composite Materials, the standing committee member of Regenerative MaterialsCommittee and Bioceramics Division of Chinese Society for Biomaterials.
Affiliation: Shandong University, China
Professor Youming Zhang is the Director of State Key Laboratory of Microbial Technology in Shandong Universitysince 2013. As one of the co-founders and chief scientific officer, he was responsible for the R&D in Gene Bridges GmbH in Germany for 13 years. Based on the invention and application of Red/ET DNA recombination technology, Youming Zhang published more than 170 scientific articles and obtained 13 international patents and more than 30 Chinese patents together with his colleagues. The technology is a powerful technology for large size DNA/genome engineering and widely used over the world by Biotech/Pharma companies and research laboratories. Youming Zhang is the member of German National Academy of Science and Engineering(acatech) and also the member of Academia Europaea.